Abstract
Introduction: The activity and regulation of inflammasome is receiving increasing attention in septic shock. Moreover, there is a growing body of evidence suggesting that mitochondrial DNA (mtDNA) can play a role as biomarker of disease severity and even mortality both in adults and children in critically ill setting. However, no data are available on the amount of circulating mtDNA and inflammasome gene expression in multi-drug resistant (MDR) bacteria septic shock. For this reason, the aim of this study was to determine whether plasma mtDNA levels and inflammasome gene expression in monocytes could be related to severity in patients admitted to intensive care unit (ICU) with septic shock due to MDR pathogens.Materials and Methods: Peripheral blood mononuclear cells (PBMC) and plasma were isolated from up to 20 ml of venous blood by density gradient centrifugation in patients admitted to ICU with the diagnosis of septic shock due to MDR-bacteria. Then, CD14+ monocytes were sorted, and RNA and DNA were extracted. NLRP3, PYCARD, AIM2 and NAIP expression level was analyzed by RT-PCR. Plasma circulating mtDNA levels were quantified by digital droplet PCR. Basal and outcome characteristics of the patients were collected. Age-matched healthy subjects were chosen as controls.Results: Nineteen patients with septic shock and 20 healthy subjects were enrolled in the study. A small trend toward an increased expression of inflammasome genes was observed in septic shock patients, who also displayed a marked tendency to an increased expression of IL-18 and IL-1β genes. Circulating mtDNA levels were significantly higher in septic shock patients if compared to healthy subjects, and patients who died in ICU were characterized by higher level of mtDNA if compared to those who were dismissed after 7 days. No correlations were found between mtDNA and inflammasome level and other clinical variables.Conclusion: Despite many limitations, our data suggest that in patients with septic shock caused by MDR pathogens the expression of main inflammasome genes was comparable to that of healthy patients without infection. Furthermore, our data evidence a possible role of mtDNA as a prognostic marker of severity in septic shock from MDR.
Highlights
The activity and regulation of inflammasome is receiving increasing attention in septic shock
We investigated whether plasma mitochondrial DNA (mtDNA) levels and inflammasome gene expression in monocytes, cells that are crucial for innate immune response, could be related to severity in patients admitted to intensive care unit (ICU) with septic shock due to multi-drug resistant (MDR) pathogens infection
Concerning mtDNA, we found that circulating mtDNA levels were significantly higher in septic shock patients if compared to controls (Figures 2A,B), and that patients who died in ICU were characterized by higher level of mtDNA if compared to those patients with septic shock who were discharged alive from the ICU (Figures 2A,B)
Summary
The activity and regulation of inflammasome is receiving increasing attention in septic shock. Recent investigations of the pathogenic host response to infection have highlighted a different behavior depending on whether there is a hyperinflammatory state or a hyporeactivity of the immune system [1] These new perspectives have brought up the role of pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) in the initiation and propagation of the inflammatory cascade. This “Danger Model” stipulates that when cells are injured they release their components into the extracellular space, which in turn drives an immune or inflammatory response [2]. Mainly in septic shock patients, there is a growing body of literature suggesting that mtDNA plasma levels can probably be used as biomarker of disease severity and even mortality both in adults and children [6,7,8]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.